
Hindcon Chemicals (HINDCON) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2024Income Metrics
Revenue
143.4M
Gross Profit
46.9M
32.70%
Operating Income
16.5M
11.48%
Net Income
18.0M
12.56%
Balance Sheet Metrics
Total Assets
595.7M
Total Liabilities
90.2M
Shareholders Equity
505.5M
Debt to Equity
0.18
Cash Flow Metrics
Revenue & Profitability Trend
Hindcon Chemicals Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 645.1M | 855.9M | 666.2M | 442.7M | 442.8M |
Cost of Goods Sold | 464.0M | 698.4M | 543.4M | 342.3M | 343.9M |
Gross Profit | 181.0M | 157.6M | 122.8M | 100.4M | 98.9M |
Gross Margin % | 28.1% | 18.4% | 18.4% | 22.7% | 22.3% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 33.8M | 22.6M | 17.7M | 21.9M |
Other Operating Expenses | 60.4M | 66.0M | 6.8M | 2.4M | 1.1M |
Total Operating Expenses | 60.4M | 99.8M | 29.5M | 20.1M | 23.0M |
Operating Income | 67.4M | 48.9M | 53.5M | 48.7M | 40.7M |
Operating Margin % | 10.5% | 5.7% | 8.0% | 11.0% | 9.2% |
Non-Operating Items | |||||
Interest Income | - | 10.7M | 7.8M | 10.6M | 8.2M |
Interest Expense | 756.0K | 503.0K | 224.0K | 147.0K | 31.4K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 83.5M | 60.2M | 60.9M | 64.5M | 42.9M |
Income Tax | 21.2M | 16.7M | 18.3M | 16.8M | 14.3M |
Effective Tax Rate % | 25.4% | 27.7% | 30.0% | 26.0% | 33.4% |
Net Income | 62.3M | 43.6M | 42.6M | 47.7M | 28.6M |
Net Margin % | 9.7% | 5.1% | 6.4% | 10.8% | 6.5% |
Key Metrics | |||||
EBITDA | 87.8M | 63.6M | 65.7M | 67.0M | 49.9M |
EPS (Basic) | - | ₹1.14 | ₹1.11 | ₹1.24 | ₹0.74 |
EPS (Diluted) | - | ₹1.14 | ₹1.11 | ₹1.24 | ₹0.74 |
Basic Shares Outstanding | - | 37885965 | 38360125 | 38360125 | 38360125 |
Diluted Shares Outstanding | - | 37885965 | 38360125 | 38360125 | 38360125 |
Income Statement Trend
Hindcon Chemicals Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 87.6M | 75.0M | 22.3M | 64.9M | 9.3M |
Short-term Investments | 32.4M | 28.4M | 32.0M | 40.4M | 25.0M |
Accounts Receivable | 222.4M | 261.8M | 263.6M | 192.1M | 198.3M |
Inventory | 15.3M | 33.2M | 35.7M | 20.3M | 21.1M |
Other Current Assets | 13.7M | 16.2M | 21.7M | 25.0M | - |
Total Current Assets | 431.9M | 477.0M | 463.1M | 374.4M | 335.6M |
Non-Current Assets | |||||
Property, Plant & Equipment | 62.5M | 984.0K | 949.0K | 890.0K | 806.0K |
Goodwill | 0 | 0 | 0 | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 708.0K | 284.0K | 32.3M | 28.2M | - |
Total Non-Current Assets | 163.8M | 59.3M | 63.0M | 57.8M | 31.8M |
Total Assets | 595.7M | 536.3M | 526.2M | 432.2M | 367.4M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 54.1M | 74.2M | 79.0M | 47.2M | 50.5M |
Short-term Debt | 0 | 9.8M | 12.4M | 9.9M | 3.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 8.5M | 2.3M | 6.0K | 5.0K | 383.8K |
Total Current Liabilities | 87.3M | 104.6M | 129.9M | 77.8M | 66.1M |
Non-Current Liabilities | |||||
Long-term Debt | 0 | 0 | 0 | - | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 2.8M | 2.9M |
Other Non-Current Liabilities | 3.0K | - | -79.0M | -47.2M | 383.8K |
Total Non-Current Liabilities | 2.9M | 3.4M | 294.0K | 139.0K | 384.0K |
Total Liabilities | 90.2M | 108.0M | 130.2M | 77.9M | 66.5M |
Equity | |||||
Common Stock | 76.7M | 76.7M | 76.7M | 76.7M | 76.7M |
Retained Earnings | - | 246.4M | 208.5M | 180.8M | 138.4M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 505.5M | 428.4M | 396.0M | 354.3M | 300.9M |
Key Metrics | |||||
Total Debt | 0 | 9.8M | 12.4M | 9.9M | 3.0M |
Working Capital | 344.6M | 372.5M | 333.2M | 296.6M | 269.5M |
Balance Sheet Composition
Hindcon Chemicals Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 83.5M | 60.2M | 60.9M | 64.5M | 42.9M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 50.2M | 7.4M | -132.7M | 10.5M | -14.2M |
Operating Cash Flow | 120.5M | 57.4M | -79.4M | 64.6M | 20.6M |
Investing Activities | |||||
Capital Expenditures | -36.4M | -15.3M | -5.4M | -4.6M | -2.3M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -51.6M | 0 | - | -16.9M | - |
Investment Sales | 4.0M | 5.5M | 16.0M | 17.9M | - |
Investing Cash Flow | -84.0M | -9.8M | 26.5M | -3.6M | -2.3M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -3.9M | -5.4M | -19.3M | -6.9M | -5.9M |
Debt Issuance | - | - | - | - | - |
Debt Repayment | -9.8M | -2.6M | - | -245.3K | -316.6K |
Financing Cash Flow | -23.5M | -10.5M | -16.8M | -220.3K | -4.6M |
Free Cash Flow | 55.4M | 38.4M | -49.9M | 43.2M | 18.9M |
Net Change in Cash | 13.0M | 37.1M | -69.7M | 60.8M | 13.7M |
Cash Flow Trend
Hindcon Chemicals Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
20.23
Price to Book
2.24
Price to Sales
3.00
Profitability Ratios
Profit Margin
9.08%
Operating Margin
6.61%
Return on Equity
12.23%
Return on Assets
10.38%
Financial Health
Current Ratio
4.95
Debt to Equity
1.13
Beta
-0.08
Per Share Data
EPS (TTM)
₹1.61
Book Value per Share
₹14.55
Revenue per Share
₹14.46
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
hindcon | 1.7B | 20.23 | 2.24 | 12.23% | 9.08% | 1.13 |
Asian Paints | 2.4T | 65.93 | 12.25 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 71.77 | 16.03 | 20.85% | 16.16% | 4.56 |
Balaji Amines | 49.9B | 32.81 | 2.71 | 7.80% | 11.11% | 0.55 |
Camlin Fine Sciences | 40.4B | 57.31 | 4.48 | -15.89% | -6.73% | 77.88 |
Grauer & Weil | 43.7B | 27.77 | 4.65 | 18.02% | 13.85% | 1.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.